Glutamyl-Prolyl-tRNA Synthetase Regulates Proline-Rich Pro-Fibrotic Protein Synthesis During Cardiac Fibrosis

Author:

Wu Jiangbin1,Subbaiah Kadiam C. Venkata1,Xie Li Huitong2,Jiang Feng13,Khor Eng-Soon1,Mickelsen Deanne1,Myers Jason R.4,Tang Wai Hong Wilson5,Yao Peng1367ORCID

Affiliation:

1. From the Aab Cardiovascular Research Institute, Department of Medicine (J.W., K.C.V.S., F.J., E.-S.K., D.M., P.Y.), University of Rochester School of Medicine & Dentistry, New York

2. Graduate Program in Genetics, Development and Stem Cells, Department of Biomedical Genetics (L.H.X.), University of Rochester School of Medicine & Dentistry, New York

3. Biochemistry & Biophysics (F.J., P.Y.), University of Rochester School of Medicine & Dentistry, New York

4. Genomics Research Center (J.R.M.), University of Rochester School of Medicine & Dentistry, New York

5. Cardiovascular Medicine, Cleveland Clinic, OH (W.H.W.T.)

6. The Center for RNA Biology (P.Y.), University of Rochester School of Medicine & Dentistry.

7. The Center for Biomedical Informatics (P.Y.), University of Rochester School of Medicine & Dentistry.

Abstract

Rationale: Increased protein synthesis of profibrotic genes is a common feature in cardiac fibrosis and heart failure. Despite this observation, critical factors and molecular mechanisms for translational control of profibrotic genes during cardiac fibrosis remain unclear. Objective: To investigate the role of a bifunctional ARS (aminoacyl-tRNA synthetase), EPRS (glutamyl-prolyl-tRNA synthetase) in translational control of cardiac fibrosis. Methods and Results: Results from reanalyses of multiple publicly available data sets of human and mouse heart failure, demonstrated that EPRS acted as an integrated node among the ARSs in various cardiac pathogenic processes. We confirmed that EPRS was induced at mRNA and protein levels (≈1.5–2.5-fold increase) in failing hearts compared with nonfailing hearts using our cohort of human and mouse heart samples. Genetic knockout of one allele of Eprs globally ( Eprs +/− ) using CRISPR-Cas9 technology or in a Postn-Cre-dependent manner ( Eprs flox/+ ; Postn MCM/+ ) strongly reduces cardiac fibrosis (≈50% reduction) in isoproterenol-, transverse aortic constriction-, and myocardial infarction (MI)-induced heart failure mouse models. Inhibition of EPRS using a PRS (prolyl-tRNA synthetase)-specific inhibitor, halofuginone, significantly decreases translation efficiency (TE) of proline-rich collagens in cardiac fibroblasts as well as TGF-β (transforming growth factor-β)-activated myofibroblasts. Overexpression of EPRS increases collagen protein expression in primary cardiac fibroblasts under TGF-β stimulation. Using transcriptome-wide RNA-Seq and polysome profiling-Seq in halofuginone-treated fibroblasts, we identified multiple novel Pro-rich genes in addition to collagens, such as Ltbp2 (latent TGF-β-binding protein 2) and Sulf1 (sulfatase 1), which are translationally regulated by EPRS. SULF1 is highly enriched in human and mouse myofibroblasts. In the primary cardiac fibroblast culture system, siRNA-mediated knockdown of SULF1 attenuates cardiac myofibroblast activation and collagen deposition. Overexpression of SULF1 promotes TGF-β-induced myofibroblast activation and partially antagonizes anti-fibrotic effects of halofuginone treatment. Conclusions: Our results indicate that EPRS preferentially controls translational activation of proline codon rich profibrotic genes in cardiac fibroblasts and augments pathological cardiac remodeling. Graphical Abstract: A graphical abstract is available for this article.

Funder

HHS | National Institutes of Health

HHS | NIH | National Center for Advancing Translational Sciences

UR | URMC | Center for AIDS Research, University of Rochester Medical Center

American Heart Association

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3